Acitelli, Elisa http://orcid.org/0009-0000-8412-5705
Guedon, Alexis F. http://orcid.org/0000-0002-4571-6219
De Liguori, Sara http://orcid.org/0009-0000-3155-5525
Gallo, Antonio http://orcid.org/0000-0002-8887-994X
Maranghi, Marianna http://orcid.org/0000-0002-3117-7488
Article History
Received: 21 January 2024
Accepted: 25 February 2024
First Online: 8 March 2024
Compliance with ethical standards
:
: M.M. worked as principal investigator in clinical trials supported by Novo Nordisk. A.G. received consulting fees or payments for lectures, presentations, manuscript writing or educational events from AMGEN, Sanofi and Regeron, Mylan, Ackea Therapeutics, Novartis, MSD, Servier, Ultragenyx. A.G. declares having received support for attending meetings and/or travel by Amryt, Novartis, Ultragenyx and Sanofi, and participated on a data safety monitoring board or advisory board for Sanofi and Ultragenyx.